Baker Ellis Asset Management LLC Bristol Myers Squibb CO Transaction History

Baker Ellis Asset Management LLC

$658 Million
Q4 2024

A detailed history of Baker Ellis Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Baker Ellis Asset Management LLC holds 5,730 shares of BMY stock, worth $321,739. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,730

Previous 5,830 1.72%

Holding current value

$321,739

Previous $301,000 7.64%

% of portfolio

0.05%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$51.92 - $59.94 $5,192 - $5,994	-100 Reduced 1.72%	5,730 $324,000
Q3 2024 Oct 15, 2024	SELL	$39.66 - $51.75 $3,965 - $5,175	-100 Reduced 1.69%	5,830 $301,000
Q2 2024 Jul 09, 2024	SELL	$40.25 - $52.99 $8,050 - $10,598	-200 Reduced 3.26%	5,930 $246,000
Q1 2024 Apr 17, 2024	SELL	$47.98 - $54.4 $19,192 - $21,760	-400 Reduced 6.13%	6,130 $332,000
Q4 2023 Jan 23, 2024	SELL	$48.48 - $57.85 $63,023 - $75,205	-1,300 Reduced 16.6%	6,530 $335,000
Q3 2023 Oct 24, 2023	SELL	$57.89 - $64.73 $15,398 - $17,218	-266 Reduced 3.29%	7,830 $454,000
Q1 2023 May 08, 2023	SELL	$65.71 - $74.53 $33,314 - $37,786	-507 Reduced 5.89%	8,096 $561,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $52 - $30,736	400 Added 4.88%	8,603 $612,000
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $36,818 - $40,549	507 Added 6.59%	8,203 $632,000
Q3 2021 Oct 15, 2021	SELL	$59.17 - $69.31 $20,709 - $24,258	-350 Reduced 4.35%	7,696 $439,000
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $20,677 - $22,518	334 Added 4.33%	8,046 $538,000
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $39,520 - $44,448	-666 Reduced 7.95%	7,712 $487,000
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $8,430 - $9,552	146 Added 1.77%	8,378 $520,000
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $17,343 - $19,219	-302 Reduced 3.54%	8,232 $496,000
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $13,047 - $15,253	-238 Reduced 2.71%	8,534 $502,000
Q4 2019 Feb 10, 2020	SELL	$49.21 - $64.19 $862,995 - $1.13 Million	-17,537 Reduced 66.66%	8,772 $563,000
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $47,047 - $55,781	-1,100 Reduced 4.01%	26,309 $1.33 Million
Q2 2019 Aug 12, 2019	SELL	$44.62 - $49.34 $11,155 - $12,335	-250 Reduced 0.9%	27,409 $1.24 Million
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $22,560 - $26,900	-500 Reduced 1.78%	27,659 $1.32 Million
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $127,409 - $165,219	-2,613 Reduced 8.49%	28,159 $1.46 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $33,114 - $37,350	-600 Reduced 1.91%	30,772 $1.91 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $77,310 - $96,359	-1,530 Reduced 4.65%	31,372 $1.74 Million
Q1 2018 Apr 19, 2018	SELL	$59.92 - $68.98 $17,976 - $20,694	-300 Reduced 0.9%	32,902 $2.08 Million
Q4 2017 Jan 30, 2018	SELL	$59.94 - $65.35 $8,991 - $9,802	-150 Reduced 0.45%	33,202 $2.04 Million
Q3 2017 Oct 18, 2017	BUY	$55.23 - $63.74 $1.84 Million - $2.13 Million	33,352	33,352 $2.13 Million

Others Institutions Holding BMY

# of Institutions

2,690

Shares Held

1.53B

Call Options Held

32M

Put Options Held

35.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Ellis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Ellis Asset Management LLC with notifications on news.

Account

Baker Ellis Asset Management LLC Bristol Myers Squibb CO Transaction History